文献速递肾小球疾病

IL-6受体经典信号新作用:诱导RORγt+Foxp3+ Treg并增强其抑制功能

A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity.
PubMed 文献 · J Am Soc Nephrol · 2019-07-16

该研究在小鼠新月体性肾小球肾炎模型中探讨CD4+ T细胞内在IL-6R信号的作用。结果显示IL-6Ra经典信号既诱导促炎Th17细胞,也诱导具有强免疫抑制功能的RORγt+Foxp3+双阳性Treg,提示IL-6靶向治疗需细胞类型特异性。

要点

  • CD4+ T细胞IL-6Ra缺失减少Th17但未改善肾小球肾炎。
  • IL-6Ra经典信号诱导RORγt+Foxp3+双阳性Treg,增强抑制功能。
  • 过继转移含IL-6Ra-/- Treg的T细胞加重肾小球肾炎。

核心结论

  • IL-6Ra经典信号同时诱导Th17和高效免疫抑制性RORγt+双阳性Treg,修正了IL-6仅增强Th17并抑制Treg的旧观点。
  • IL-6靶向治疗用于肾小球肾炎需考虑细胞类型特异性。

研究设计与样本

  • 研究采用小鼠肾毒性肾炎模型(新月体性GN模型)。
  • 使用T细胞特异性IL-6Ra缺失小鼠、过继转移实验和报告基因小鼠分析免疫应答与Treg亚群。

主要发现

  • 小鼠CD4+ T细胞缺乏IL-6Ra信号损害促炎Th17细胞生成,但未改善GN病程。
  • 将IL-6Ra缺陷限制于效应T细胞并排除Treg时,肾损伤显著减轻。
  • IL-6Ra缺陷时Treg的IL-10产生未改变。
  • 体内外IL-6Ra经典信号诱导携带CCR6的RORγt+Foxp3+双阳性Treg(biTregs),具强免疫调节特性。
  • IL-6Ra缺失显著降低Treg体外抑制能力;过继转移含IL-6Ra-/- Treg的T细胞导致GN严重加重。

临床怎么用

  • 提示IL-6阻断疗法在肾小球肾炎中的应用需谨慎,并应针对特定细胞类型设计。

局限性

  • 研究为小鼠模型实验,结论外推至人类肾小球肾炎需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: New therapies blocking the IL-6 receptor (IL-6R) have recently become available and are successfully being used to treat inflammatory diseases like arthritis. Whether IL-6 blockers may help patients with kidney inflammation currently remains unknown. METHODS: To learn more about the complex role of CD4+ T cell-intrinsic IL-6R signaling, we induced nephrotoxic nephritis, a mouse model for crescentic GN, in mice lacking T cell-specific IL-6Ra. We used adoptive transfer experiments and studies in reporter mice to analyze immune responses and Treg subpopulations. RESULTS: Lack of IL-6Ra signaling in mouse CD4+ T cells impaired the generation of proinflammatory Th17 cells, but surprisingly did not ameliorate the course of GN. In contrast, renal damage was significantly reduced by restricting IL-6Ra deficiency to T effector cells and excluding Tregs. Detailed studies of Tregs revealed unaltered IL-10 production despite IL-6Ra deficiency. However, in vivo and in vitro, IL-6Ra classic signaling induced RORγt+Foxp3+ double-positive Tregs (biTregs), which carry the trafficking receptor CCR6 and have potent immunoregulatory properties. Indeed, lack of IL-6Ra significantly reduced Treg in vitro suppressive capacity. Finally, adoptive transfer of T cells containing IL-6Ra-/- Tregs resulted in severe aggravation of GN in mice. CONCLUSIONS: Our data refine the old paradigm, that IL-6 enhances Th17 responses and suppresses Tregs. We here provide evidence that T cell-intrinsic IL-6Ra classic signaling indeed induces the generation of Th17 cells but at the same time highly immunosuppressive RORγt+ biTregs. These results advocate caution and indicate that IL-6-directed therapies for GN need to be cell-type specific.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hagenstein J, Melderis S, Nosko A, et al. A Novel Role for IL-6 Receptor Classic Signaling: Induction of RORγt+Foxp3+ Tregs with Enhanced Suppressive Capacity. J Am Soc Nephrol. 2019. PMID: 31311828. doi:10.1681/ASN.2019020118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。